Effects of 17-Hydroxyprogesterone on Tumor Necrosis Factor- -Induced Hypertension During Pregnancy | Zendy

Sharon Keiser | Zendy; Edward Veillon | Zendy; Marc Parrish | Zendy; William A. Bennett | Zendy; Kathy Cockrell | Zendy; Lison Fournier | Zendy; Joey P. Granger | Zendy; James N. Martin | Zendy; Babbette LaMarca | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Effects of 17-Hydroxyprogesterone on Tumor Necrosis Factor- -Induced Hypertension During Pregnancy

Author(s) -

Sharon Keiser,

Edward Veillon,

Marc Parrish,

William A. Bennett,

Kathy Cockrell,

Lison Fournier,

Joey P. Granger,

James N. Martin,

Babbette LaMarca

Publication year - 2009

Publication title -

american journal of hypertension

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.009

H-Index - 136

eISSN - 1941-7225

pISSN - 0895-7061

DOI - 10.1038/ajh.2009.149

Subject(s) - medicine , endocrinology , tumor necrosis factor alpha , preeclampsia , blood pressure , alpha (finance) , kidney , pregnancy , biology , construct validity , nursing , patient satisfaction , genetics

Inflammatory cytokines such as tumor necrosis factor-alpha (TNF-alpha) may be an important link between placental ischemia and hypertension in preeclampsia. We examined the effect of 17-hydroxyprogesterone caproate (17-OHP) on TNF-alpha-stimulated endothelin (ET) production and hypertension during pregnancy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research